i4C - Strengthening global health international collaboration View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2014-2019

FUNDING AMOUNT

24661972 NOK

ABSTRACT

Our main research question is how can international collaboration be strengthened to scale-up cost-effective and life-saving commodities, especially for the world's poorest women and children. We will pursue this question by evaluating eight policy interventions directed at global health governance institutions. Five aim to improve global access to existing, life-saving commodities. These include: 1) evaluating the impact of free trade agreements and regulatory harmonization; 2) examining how emerging economies like Brazil, India and China promote access on the international stage to provide learning for other developing economies; 3) assessing advocacy strategies for promoting evidence-informed policymaking; 4) evaluating existing and new global health governance architecture's contributions to improving access; and 5) considering the role of existing and potentially new international legal mechanisms. Three aim to improve prioritization, financing and incentives for global innovation of new, life-saving commodities. This includes: 6) developing a multi-criteria priority classification model for value-based R&D investments; 7) proposing an R&D investment prioritization framework; and 8) examining global incentives to increase R&D investment in antibiotics. These interventions represent options across all four types of global governance arrangements; international rules (1,5), norms and discourses (2,3), market interventions (6,7), and access to domestic policy processes (4,8). Building on the diverse disciplinary expertise of the research team, each intervention is evaluated using a tailored social science method that is most appropriate, whether that is economic modeling (6-8), interrupted time-series analyses (1,5), interviews and document analyses (1,2,6,7), legal analyses (4,5,8), policy analyses (4,8), political analyses (2,3,8), simulation (7), surveys (1,6) or systematic reviews (5,7). More... »

URL

https://www.forskningsradet.no/prosjektbanken/#/project/NFR/234608/Sprak=en

Related SciGraph Publications

  • 2019-12. Probing popular and political discourse on antimicrobial resistance in China in GLOBAL HEALTH RESEARCH AND POLICY
  • 2018-12. Defining the global health system and systematically mapping its network of actors in GLOBALIZATION AND HEALTH
  • 2018-12. Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations in JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
  • 2018-08. Contested roles of Canada’s Chief Medical Officers of Health in CANADIAN JOURNAL OF PUBLIC HEALTH
  • 2017-12. Government policy interventions to reduce human antimicrobial use: protocol for a systematic review and meta-analysis in SYSTEMATIC REVIEWS
  • 2017-10-06. Market watch: Innovation in the preclinical antibiotic pipeline in NATURE REVIEWS DRUG DISCOVERY
  • 2016-12. Is the UN Convention on the Rights of Persons with Disabilities Impacting Mental Health Laws and Policies in High-Income Countries? A Case Study of Implementation in Canada in BMC INTERNATIONAL HEALTH AND HUMAN RIGHTS
  • 2016-12. International law’s effects on health and its social determinants: protocol for a systematic review, meta-analysis, and meta-regression analysis in SYSTEMATIC REVIEWS
  • 2016-12. An assessment of the future impact of alternative technologies on antibiotics markets in JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
  • 2016-12. Empirically evaluating the WHO global code of practice on the international recruitment of health personnel’s impact on four high-income countries four years after adoption in GLOBALIZATION AND HEALTH
  • 2016-12. Developing an approach to assessing the political feasibility of global collective action and an international agreement on antimicrobial resistance in GLOBAL HEALTH RESEARCH AND POLICY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2216", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2218", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2214", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2216", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "NOK", 
          "type": "MonetaryAmount", 
          "value": "24661972"
        }, 
        "description": "Our main research question is how can international collaboration be strengthened to scale-up cost-effective and life-saving commodities, especially for the world's poorest women and children. We will pursue this question by evaluating eight policy interventions directed at global health governance institutions. Five aim to improve global access to existing, life-saving commodities. These include: 1) evaluating the impact of free trade agreements and regulatory harmonization; 2) examining how emerging economies like Brazil, India and China promote access on the international stage to provide learning for other developing economies; 3) assessing advocacy strategies for promoting evidence-informed policymaking; 4) evaluating existing and new global health governance architecture's contributions to improving access; and 5) considering the role of existing and potentially new international legal mechanisms. Three aim to improve prioritization, financing and incentives for global innovation of new, life-saving commodities. This includes: 6) developing a multi-criteria priority classification model for value-based R&D investments; 7) proposing an R&D investment prioritization framework; and 8) examining global incentives to increase R&D investment in antibiotics. These interventions represent options across all four types of global governance arrangements; international rules (1,5), norms and discourses (2,3), market interventions (6,7), and access to domestic policy processes (4,8). Building on the diverse disciplinary expertise of the research team, each intervention is evaluated using a tailored social science method that is most appropriate, whether that is economic modeling (6-8), interrupted time-series analyses (1,5), interviews and document analyses (1,2,6,7), legal analyses (4,5,8), policy analyses (4,8), political analyses (2,3,8), simulation (7), surveys (1,6) or systematic reviews (5,7).", 
        "endDate": "2019-12-31T00:00:00Z", 
        "funder": {
          "id": "https://www.grid.ac/institutes/grid.13985.36", 
          "type": "Organization"
        }, 
        "id": "sg:grant.4639944", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "4639944"
            ]
          }, 
          {
            "name": "rcn_id", 
            "type": "PropertyValue", 
            "value": [
              "234608"
            ]
          }
        ], 
        "inLanguage": [
          "en"
        ], 
        "keywords": [
          "poor women", 
          "global access", 
          "financing", 
          "Brazil", 
          "values", 
          "global health governance institutions", 
          "question", 
          "advocacy strategies", 
          "regulatory harmonization", 
          "global governance arrangements", 
          "policy analysis", 
          "intervention", 
          "evidence", 
          "social science methods", 
          "political analysis", 
          "policy interventions", 
          "discourse", 
          "impact", 
          "children", 
          "main research question", 
          "world", 
          "research team", 
          "interviews", 
          "Emerging Economy", 
          "policymaking", 
          "antibiotics", 
          "international collaboration", 
          "diverse disciplinary expertise", 
          "cost", 
          "legal analysis", 
          "type", 
          "international stage", 
          "aim", 
          "access", 
          "multi-criteria priority classification model", 
          "economic modeling", 
          "R&D investment", 
          "systematic review", 
          "new global health governance architecture's contributions", 
          "simulation", 
          "global innovation", 
          "domestic policy processes", 
          "global health", 
          "global incentives", 
          "learning", 
          "international rules", 
          "option", 
          "time-series analysis", 
          "role", 
          "India", 
          "China", 
          "free trade agreements", 
          "incentives", 
          "prioritization", 
          "survey", 
          "document analysis", 
          "R&D investment prioritization framework", 
          "life", 
          "commodity", 
          "economy", 
          "new international legal mechanisms", 
          "market intervention", 
          "norms"
        ], 
        "name": "i4C - Strengthening global health international collaboration", 
        "recipient": [
          {
            "id": "https://www.grid.ac/institutes/grid.418193.6", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.418193.6", 
              "name": "FOLKEHELSEINSTITUTTET", 
              "type": "Organization"
            }, 
            "familyName": "Ottersen", 
            "givenName": "Trygve", 
            "id": "sg:person.0766505131.31", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.0766505131.31", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.4639944"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2021-01-18T10:13", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/rcn_projects.xml.gz", 
        "startDate": "2014-01-01T00:00:00Z", 
        "type": "MonetaryGrant", 
        "url": "https://www.forskningsradet.no/prosjektbanken/#/project/NFR/234608/Sprak=en"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.4639944'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.4639944'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.4639944'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.4639944'


     

    This table displays all metadata directly associated to this object as RDF triples.

    113 TRIPLES      19 PREDICATES      87 URIs      77 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.4639944 schema:about anzsrc-for:2214
    2 anzsrc-for:2216
    3 anzsrc-for:2218
    4 schema:amount N61f8aa22f5e4498f85dbcdaa68ae73e4
    5 schema:description Our main research question is how can international collaboration be strengthened to scale-up cost-effective and life-saving commodities, especially for the world's poorest women and children. We will pursue this question by evaluating eight policy interventions directed at global health governance institutions. Five aim to improve global access to existing, life-saving commodities. These include: 1) evaluating the impact of free trade agreements and regulatory harmonization; 2) examining how emerging economies like Brazil, India and China promote access on the international stage to provide learning for other developing economies; 3) assessing advocacy strategies for promoting evidence-informed policymaking; 4) evaluating existing and new global health governance architecture's contributions to improving access; and 5) considering the role of existing and potentially new international legal mechanisms. Three aim to improve prioritization, financing and incentives for global innovation of new, life-saving commodities. This includes: 6) developing a multi-criteria priority classification model for value-based R&D investments; 7) proposing an R&D investment prioritization framework; and 8) examining global incentives to increase R&D investment in antibiotics. These interventions represent options across all four types of global governance arrangements; international rules (1,5), norms and discourses (2,3), market interventions (6,7), and access to domestic policy processes (4,8). Building on the diverse disciplinary expertise of the research team, each intervention is evaluated using a tailored social science method that is most appropriate, whether that is economic modeling (6-8), interrupted time-series analyses (1,5), interviews and document analyses (1,2,6,7), legal analyses (4,5,8), policy analyses (4,8), political analyses (2,3,8), simulation (7), surveys (1,6) or systematic reviews (5,7).
    6 schema:endDate 2019-12-31T00:00:00Z
    7 schema:funder https://www.grid.ac/institutes/grid.13985.36
    8 schema:identifier N16db8b15fefa4fec8fc4556ca1a90dc2
    9 N63f7d46c6de744b68e7cb113423ced58
    10 schema:inLanguage en
    11 schema:keywords Brazil
    12 China
    13 Emerging Economy
    14 India
    15 R&D investment
    16 R&D investment prioritization framework
    17 access
    18 advocacy strategies
    19 aim
    20 antibiotics
    21 children
    22 commodity
    23 cost
    24 discourse
    25 diverse disciplinary expertise
    26 document analysis
    27 domestic policy processes
    28 economic modeling
    29 economy
    30 evidence
    31 financing
    32 free trade agreements
    33 global access
    34 global governance arrangements
    35 global health
    36 global health governance institutions
    37 global incentives
    38 global innovation
    39 impact
    40 incentives
    41 international collaboration
    42 international rules
    43 international stage
    44 intervention
    45 interviews
    46 learning
    47 legal analysis
    48 life
    49 main research question
    50 market intervention
    51 multi-criteria priority classification model
    52 new global health governance architecture's contributions
    53 new international legal mechanisms
    54 norms
    55 option
    56 policy analysis
    57 policy interventions
    58 policymaking
    59 political analysis
    60 poor women
    61 prioritization
    62 question
    63 regulatory harmonization
    64 research team
    65 role
    66 simulation
    67 social science methods
    68 survey
    69 systematic review
    70 time-series analysis
    71 type
    72 values
    73 world
    74 schema:name i4C - Strengthening global health international collaboration
    75 schema:recipient Nc7d095afb8bf4920b724a7676d84cf48
    76 sg:person.0766505131.31
    77 https://www.grid.ac/institutes/grid.418193.6
    78 schema:sameAs https://app.dimensions.ai/details/grant/grant.4639944
    79 schema:sdDatePublished 2021-01-18T10:13
    80 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    81 schema:sdPublisher Nb4f31ced9eab4805bc129520b81fd9e8
    82 schema:startDate 2014-01-01T00:00:00Z
    83 schema:url https://www.forskningsradet.no/prosjektbanken/#/project/NFR/234608/Sprak=en
    84 sgo:license sg:explorer/license/
    85 sgo:sdDataset grants
    86 rdf:type schema:MonetaryGrant
    87 N16db8b15fefa4fec8fc4556ca1a90dc2 schema:name rcn_id
    88 schema:value 234608
    89 rdf:type schema:PropertyValue
    90 N61f8aa22f5e4498f85dbcdaa68ae73e4 schema:currency NOK
    91 schema:value 24661972
    92 rdf:type schema:MonetaryAmount
    93 N63f7d46c6de744b68e7cb113423ced58 schema:name dimensions_id
    94 schema:value 4639944
    95 rdf:type schema:PropertyValue
    96 Nb4f31ced9eab4805bc129520b81fd9e8 schema:name Springer Nature - SN SciGraph project
    97 rdf:type schema:Organization
    98 Nc7d095afb8bf4920b724a7676d84cf48 schema:member sg:person.0766505131.31
    99 schema:roleName PI
    100 rdf:type schema:Role
    101 anzsrc-for:2214 schema:inDefinedTermSet anzsrc-for:
    102 rdf:type schema:DefinedTerm
    103 anzsrc-for:2216 schema:inDefinedTermSet anzsrc-for:
    104 rdf:type schema:DefinedTerm
    105 anzsrc-for:2218 schema:inDefinedTermSet anzsrc-for:
    106 rdf:type schema:DefinedTerm
    107 sg:person.0766505131.31 schema:affiliation https://www.grid.ac/institutes/grid.418193.6
    108 schema:familyName Ottersen
    109 schema:givenName Trygve
    110 rdf:type schema:Person
    111 https://www.grid.ac/institutes/grid.13985.36 schema:Organization
    112 https://www.grid.ac/institutes/grid.418193.6 schema:name FOLKEHELSEINSTITUTTET
    113 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...